The company said, “Ceribell (CBLL) is raising its revenue guidance for the full year 2025 to a range of $83 million to $87 million, representing growth of approximately 27% to 33% over the company’s prior year revenue.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBLL:
- Ceribell reports Q1 EPS (36c), consensus (46c)
- Ceribell announces EEG system received full RedRAMP High authorization
- Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating
- Ceribell announces FDA grants clearance for next-gen Ceribell Clarity algorithm
- Ceribell jumps after saying no impact from incremental tariffs until Q4